Korean J Physiol Pharmacol.
1999 Aug;3(4):393-404.
Reoxygenation stimulates EDRF(s) release from endothelial cells of rabbit aorta
- Affiliations
-
- 1Department of Physiology, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul, 110-799 South Korea.
Abstract
-
We have reported that hypoxia stimulates EDRF(s) release from
endothelial cells and the release may be augmented by previous hypoxia.
As a mechanism, it was hypothesized that reoxygenation can stimulate
EDRF(s) release from endothelial cells and we tested the hypothesis via
bioassay experiment. In the bioassay experiment, rabbit aorta with
endothelium was used as EDRF donor vessel and rabbit carotid artery
without endothelium as a bioassay test ring. The test ring was
contracted by prostaglandin F2a (3 X 10-6 M) which was added to the
solution perfusing through the aorta. Hypoxia was evoked by switching
the solution aerated with 95% O2/5% CO2 mixed gas to one aerated with
95% N2/5% CO2 mixed gas Hypoxia/reoxygenation were interexchanged at
intervals of 2 minutes (intermittent hypoxia). In some experiments,
endothelial cells were exposed to 10-minute hypoxia (continuous
hypoxia) and then exposed to reoxygenation and intermittent hypoxia. In
other experiments, the duration of re oxygenation was extended from 2
minutes to 5 minutes. When the donor aorta was exposed to intermittent
hypoxia, hypoxia stimulated EDRF(s) release from endothelial cells and
the hypoxia-induced EDRF(s) release was augmented by previous
hypoxia/reoxygenation. When the donor aorta was exposed to continuous
hypoxia, there was no increase of hypoxia-induced EDRF(s) release
during hypoxia. But, after the donor aorta was exposed to
reoxygenation, hypoxia-induced EDRF(s) release was markedly increased.
When the donor aorta was pretreated with nitro-L-arginine (10-5 M for
30 minutes), the initial hypoxia-induced EDRF(s) release was almost
completely abolished, but the mechanism for EDRF(s) release by the
reoxygenation and subsequent hypoxia still remained to be clarified.
TEA also blocked incompletely hypoxia-induced and
hypoxia/reoxygenation-induced EDRF(s) release EDRF(s) release by
repetitive hypoxia and reoxygenation was completely blocked by the
combined treatment with nitro-L-arginine and TEA. Cytochrome P450
blocker, SKF-525A, inhibited the EDRF(s) release reversibly and
endothelin antgonists, BQ 123 and BQ 788, had no effect on the release
of endothelium-derived vasoactive factors. Superoxide dismutase (SOD)
and catalase inhibited the EDRF(s) release from endothelial cells. From
these data, it could be concluded that reoxygenation stimulates EDRF(s)
release and hypoxia/reoxygenation can release not only NO but also
another EDRF from endothelial cells by the production of oxygen free
radicals.